Cough tratment
Reading File
Finding Sources
Searching PubMed
"cough" AND "treatment"
Finding Sources
Searching the Web
cough treatment guidelines 2025 antitussive expectorant
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Here is a thorough, organized overview of cough treatment based on authoritative medical textbooks and current guidelines.
Cough Treatment
First Step: Classify by Duration
Before treating, classify the cough by duration, as this determines the likely cause and approach:
| Type | Duration | Common Causes |
|---|---|---|
| Acute | < 3 weeks | Viral URTI, acute bronchitis, pneumonia, asthma exacerbation |
| Subacute | 3-8 weeks | Post-infectious cough, upper airway cough syndrome (UACS), pertussis |
| Chronic | > 8 weeks | Post-nasal drip/UACS, asthma, GERD, ACE inhibitor use, chronic bronchitis, malignancy |
Red Flags Requiring Urgent Evaluation
Always investigate further if there is:
- Hemoptysis
- New cough in a smoker > 45 years, or any smoker aged 55-80 with ≥ 30 pack-year history
- Change in voice or character of an existing cough
- Prominent dyspnea at rest or at night, hoarseness, fever, weight loss, or dysphagia
- History of recurrent pneumonia
- Abnormality on physical exam or imaging
(Murray & Nadel's Textbook of Respiratory Medicine)
Acute Cough Treatment
Most acute cough episodes are viral in origin and self-limiting. The primary rule is "do no harm" - treat conservatively.
- No antibiotics for viral URTI unless symptoms persist > 3 weeks or there is clear evidence of bacterial sinusitis or pneumonia
- Supportive care: rest, hydration, honey (especially in children)
- Symptomatic relief with antitussives or expectorants (see below)
- Asthma/COPD exacerbations: inhaled bronchodilators (beta-agonists, ipratropium)
Chronic Cough: Treat the Underlying Cause
The most effective approach is identifying and treating the root cause. A careful history alone leads to the correct diagnosis in ~70% of patients.
1. Post-nasal Drip / Upper Airway Cough Syndrome (most common cause)
- First-generation antihistamines (e.g., chlorpheniramine) - preferred; second-generation have limited evidence
- Intranasal corticosteroids (e.g., fluticasone) for allergic rhinitis
- Ipratropium nasal spray for non-allergic rhinitis
- Decongestants for nasal congestion
2. Asthma / Cough-Variant Asthma
- Inhaled corticosteroids (ICS) - mainstay (e.g., beclometasone, fluticasone)
- Short-acting beta-agonists (SABA) for acute relief (e.g., salbutamol/albuterol)
- Long-acting beta-agonists (LABA) added if ICS alone is insufficient
3. GERD
- Proton pump inhibitors (e.g., omeprazole 20-40 mg daily) - first line
- H2 antagonists (e.g., ranitidine) as alternatives
- Lifestyle modifications: elevate head of bed, avoid late meals, reduce alcohol/caffeine
4. ACE Inhibitor-Induced Cough
- Discontinue the ACE inhibitor and switch to an ARB (e.g., losartan) - cough typically resolves within 1-4 weeks
5. Eosinophilic Bronchitis (non-asthmatic)
- Inhaled corticosteroids
Non-Specific Cough Suppression (Symptomatic Treatment)
Note: Evidence for non-specific cough suppression agents is limited. Choice can be guided by safety profile and patient preference given the significant placebo effect in cough. (Goldman-Cecil Medicine)
| Drug | Class | Use | Notes |
|---|---|---|---|
| Dextromethorphan | Antitussive (central) | Dry, non-productive cough | OTC; first-line non-opioid suppressant |
| Guaifenesin | Expectorant | Productive cough with mucus | Only FDA-approved expectorant; loosens secretions |
| Codeine | Opioid antitussive | Persistent dry cough | Prescription-only; discouraged in children; risk of dependence |
| Benzonatate | Peripheral antitussive | Dry cough | Numbs stretch receptors in airways |
| Ipratropium | Anticholinergic | Post-infectious / post-nasal drip cough | Reduces mucus and cough reflex |
Combination OTC products (antihistamine + decongestant + antitussive) have modest benefits over placebo but may cause unnecessary side effects - targeted single-agent therapy is preferred.
Emerging Treatments for Chronic Refractory Cough
Discussed at CHEST 2025 and in recent literature:
- P2X3 antagonists (e.g., gefapixant) - block ATP-mediated cough hypersensitivity; approved or in trials for refractory chronic cough
- Neuromodulators (e.g., gabapentin, pregabalin, amitriptyline) - help in neuropathic/hypersensitivity cough
- Opioids (low-dose morphine) - for palliation in serious respiratory illness, supported by a 2024 Cochrane-type meta-analysis (PMID: 39384304)
- Speech therapy / behavioral modification - effective even when cough has an organic cause; useful for habitual or psychogenic cough components
Special Populations
- Children: Honey (1-2 tsp at night) has evidence for cough relief; codeine is contraindicated; foreign body aspiration must always be excluded
- Smokers with chronic cough: Smoking cessation is the most effective treatment; screen for COPD, bronchiectasis, and malignancy
- Immunocompromised / HIV: Extended workup including TB, PCP, fungal infections before empiric treatment
- Pregnancy: First-generation antihistamines and steam inhalation are relatively safe; avoid codeine especially in third trimester
When to Refer / Escalate
- No response to 2-3 weeks of empiric therapy
- Abnormal chest X-ray in a smoker or elderly patient
- Suspected malignancy, TB, or interstitial lung disease
- Consider HRCT or bronchoscopy if cause remains unclear after initial workup
(Sources: Textbook of Family Medicine 9e; Murray & Nadel's Textbook of Respiratory Medicine; Goldman-Cecil Medicine)
This is a shared conversation. Sign in to Orris to start your own chat.